Skip to content
MedsAcross

Medicine

Pirfenidone 801 mg tablet

Pirfenidone · Oral
Available on requestPrescription onlyUS FDAGeneric name

Pirfenidone 801 mg tablet is a generic prescription medicine for oral use, made by 21 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C…

Key facts

Active ingredient (INN)
Pirfenidone
Brand
Sold under the generic name
Strength
801 mg
Dosage form
Tablet
Route
Oral
Packs
500 tablets, 90 tablets, 1 bottle and 27 more
Manufacturers
Alembic PharmaceuticalsIndiaCiplaIndiaNovadoz PharmaceuticalsIndiaAccord HealthcareIndiaAurobindo PharmaIndiaCamber PharmaceuticalsIndiaLaurus LabsIndiaMicro LabsIndiaAmneal Pharmaceuticals NYBryant Ranch Prepack
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
L04AX05 Pirfenidone
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
29 March 2022
Identifiers
RxCUI 1868014, 1868018, 1592279 +2DailyMed set ID a235768d-d26d-4ded-ae75-53e93310ff6a, 1927bf5d-1ef3-4a36-8dac-dc0a45b72fec, 155b948e-47f5-4741-8e82-2ed65ccfab7d +21NDC 69238-1641, 69097-988, 50228-443 +21Application ANDA212570, ANDA212078, ANDA212722 +9

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
500 tablet, coated in 1 bottle46708-480-71Alembic PharmaceuticalsIndia10 June 2022
90 tablet, coated in 1 bottle46708-480-90Alembic PharmaceuticalsIndia10 June 2022
500 tablet, coated in 1 bottle62332-480-71Alembic PharmaceuticalsIndia10 June 2022
90 tablet, coated in 1 bottle62332-480-90Alembic PharmaceuticalsIndia10 June 2022
90 tablet, film coated in 1 bottle, plastic16729-468-15Accord HealthcareIndia27 May 2022
1 bottle in 1 carton / 90 tablet in 1 bottle59651-239-90Aurobindo PharmaIndia11 August 2025
90 tablet, film coated in 1 bottle31722-873-90Camber PharmaceuticalsIndia21 September 2022
90 tablet, coated in 1 bottle69097-988-05CiplaIndia2 August 2022
270 tablet, coated in 1 bottle69097-988-93CiplaIndia2 August 2022
90 tablet, film coated in 1 bottle42385-926-90Laurus LabsIndia19 July 2022
90 bottle in 1 carton / 90 tablet, film coated in 1 bottle42571-336-90Micro LabsIndia1 December 2022
3 bottle in 1 carton / 30 tablet, film coated in 1 bottle72205-182-36Novadoz PharmaceuticalsIndia8 September 2022
90 tablet, film coated in 1 bottle72205-182-90Novadoz PharmaceuticalsIndia8 September 2022
1 bottle, plastic in 1 carton / 90 tablet, film coated in 1 bottle, plastic60219-1641-9Amneal Pharmaceuticals NY29 March 2022
1 bottle, plastic in 1 carton / 90 tablet, film coated in 1 bottle, plastic69238-1641-9Amneal Pharmaceuticals NY28 February 2023
90 tablet, film coated in 1 bottle70954-870-10ANI Pharmaceuticals19 July 2022
90 tablet in 1 bottle60505-4682-9Apotex9 April 2024
90 tablet, film coated in 1 bottle82249-116-90Civica Script2 November 2026
270 tablet, coated in 1 bottle76282-716-27Exelan Pharmaceuticals2 August 2022
90 tablet, coated in 1 bottle76282-716-90Exelan Pharmaceuticals2 August 2022
90 tablet, film coated in 1 bottle, plastic0781-8086-92Sandoz2 May 2022
500 tablet in 1 bottle50228-443-05ScieGen Pharmaceuticals1 August 2022
30 tablet in 1 bottle50228-443-30ScieGen Pharmaceuticals1 August 2022
90 tablet, film coated in 1 bottle0480-3611-98Teva Pharmaceuticals11 May 2022
90 tablet, coated in 1 bottle71335-2984-1Bryant Ranch Prepack30 October 2025
90 tablet, coated in 1 bottle72162-2466-9Bryant Ranch Prepack6 March 2025
1 bottle in 1 carton / 90 tablet, film coated in 1 bottle42291-492-09AvKARE18 October 2023
90 tablet in 1 bottle51407-914-90Golden State Medical Supply30 April 2024
90 tablet, film coated in 1 bottle0904-7398-89Major Pharmaceuticals2 March 2024
90 tablet, film coated in 1 bottle72603-259-01Northstar Rx1 July 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 15 October 2014Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Pirfenidone 801 mg tablet.

Compare 1

Other strengths and forms of Pirfenidone

Clinical summary

Pirfenidone is a pyridone indicated for the treatment of idiopathic pulmonary fibrosis (IPF). It is available as tablets and capsules for oral use. MedsAcross supplies Pirfenidone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Pirfenidone

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Pirfenidone 801 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.